Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis
article
OA: closed
CC0
⤵ 67 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the endocrine effects of prolonged RU486 administration in patients diagnosed with pelvic endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (29)
- Accelerated dissolution of luteal-endometrial integrity by the administration of antagonists of gonadotropin-releasing hormone and progesterone to late-luteal phase women via openalex
- Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy via openalex
- Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. via openalex
- W1554212009 via openalex
- W1972260789 via openalex
- W1974272316 via openalex
- W1976834739 via openalex
- W1979832282 via openalex
- W2027549819 via openalex
- W2038527370 via openalex
- W2039774379 via openalex
- W2073836271 via openalex
- W2108976724 via openalex
- W2123015098 via openalex
- W2196542788 via openalex
- W2229007829 via openalex
- W2340891687 via openalex
- W2401336630 via openalex
- W2411716433 via openalex
- W2413597658 via openalex
- W2477008945 via openalex
- W4296792067 via openalex
- W6600817286 via openalex
- W6608033326 via openalex
- W6633104703 via openalex
- W19985965 via openalex
- W6715741853 via openalex
- W194498629 via openalex
- W614906504 via openalex
Cited by (50)
- Progesterone resistance in endometriosis: A pathophysiological perspective and potential treatment alternatives 2024
- Role of medical treatment of endometriosis 2021
- Selective Progesterone Receptor Modulators (SPRMs) and Androgen Receptor Modulators (SARMs) as Treatment for Benign Gynecologic Diseases 2021
- Endometriosis 2021
- 90 YEARS OF PROGESTERONE: Selective progesterone receptor modulators in gynaecological therapies 2020
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? 2018
- Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies 2018
- Investigational drugs for the treatment of endometriosis, an update on recent developments 2018
- Mifepristone 2.5, 5, 10mg versus placebo in the treatment of endometriosis 2015
- Novel Medical Treatment Modalities of Endometriosis 2015
- An overview of early drug development for endometriosis 2015
- Antiprogestins in gynecological diseases 2014
- Endometriosis 2013
- Report on Repeated Mifepristone Treatment for Uterine Fibroids or Endometriosis 2013
- Medical treatment improves social behavior in a primate endometriosis model (<i><scp>C</scp>allithrix jacchus</i>) 2013
- Endometriosis 2012
- Progesterone Receptor Modulators Induce Apoptosis in Mammary Tumors and Uterine Leiomyomas 2012
- Progesterone Resistance and Targeting the Progesterone Receptors: A Therapeutic Approach to Endometriosis 2012
- Tratamiento de la endometriosis con 5mg o 25mg diarios de mifepristona durante 6 meses. Ensayo clínico aleatorizado, doble ciego 2011
- Brief update on endometriosis treatment 2011
- Mifepristone: where do we come from and where are we going? 2010
- A novel mifepristone-loaded implant for long-term treatment of endometriosis: In vitro and in vivo studies 2010
- CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis 2010
- Use of Mifepristone to Treat Endometriosis: A Review of Clinical Trials and Trial-Like Studies Conducted in China 2010
- Medical treatment of endometriosis. 2009
- Endometriosis 2009
- Selective progesterone receptor modulators 2: use in reproductive medicine 2008
- Treatment strategies for endometriosis 2008
- New drugs in development for the treatment of endometriosis 2008
- Investigational developments for the treatment of progesterone-dependent diseases 2008
- Medical Management of Endometriosis 2008
- Emerging drugs for endometriosis 2008
- Endometriosis 2007
- Der derzeitige Stand der konservativen Therapie der Endometriose 2006
- Medical Management of Endometriosis 2006
- Future Perspectives in the Medical Treatment of Endometriosis 2005
- Emerging drugs for endometriosis 2004
- New medical treatments for endometriosis 2004
- Diagnosis and treatment of endometriosis 2003
- Effect of long-term treatment with low-dose mifepristone on the endometrium 2003
- Endometriosis 2003
- A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas 2002
- Progesterone receptor modulators and progesterone antagonists in women's health 2000
- Medical Treatment of Endometriosis-Associated Pain 1999
- Endometriosis and Pelvic Pain 1998
- Chronic Antiprogestin Therapy Produces a Stable Atrophic Endometrium With Decreased Fibroblast Growth Factor: A 1-Year Primate Study on Contraception and Amenorrhea 1998
- MODERN MEDICAL MANAGEMENT OF ENDOMETRIOSIS 1997
- The effect of RU 486 and related compounds on cultured macrophage differentiation and function 1996
- Inhibition of ovulation by progestin analogs (agonists vs antagonists): Preliminary evidence for different sites and mechanisms of actions 1996
- Mifepristone: Clinical Application in General Gynecology 1996
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:11:54.876058+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK